Medicine

A genetic therapy that increases or lowers levels of a protein raises hopes for a treatment for neurological disorders

People who receive either therapy soon after infection have a 90 percent survival rate, a clinical trial finds

Nearly half of bacteria gathered in public settings around the city were resistant to two or more commonly used antibiotics, such as penicillin and erythromycin. Christopher Intagliata reports.

Principles of evolution and natural selection drive a radical new approach to drugs and prevention strategies

Our aggressive, expensive approach to cancer is doing more harm than good

But strong regulation is a must to protect patient safety

A surprising resurgence of psychedelic research has produced its first FDA-approved treatment, with more likely on the way

The drug-resistant form of the virus has been detected at unacceptable levels across Africa, Asia and the Americas

Although the hormone has few serious short-term side effects, its long-term risks remain a black box

Violence in the Democratic Republic of the Congo has interrupted clinical trials and forced scientists to change how they immunize people

Philosopher Jacob Stegenga, author of a scathing critique of medicine, discusses vaccines and his own health

Seema Yasmin, director of research and education at the Stanford Health Communication Initiative, talks about her book The Impatient Dr. Lange: One Man’s Fight to End the Global HIV Epidemic. Lange was killed five years ago today when flight MH17 was shot down.